Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02517294 · ClinicalTrials.gov registry record · NA
, "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"
A NA study of Epistaxis, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
- 1
- Study location
NCT02517294 is a NA study of Epistaxis that has completed, run by Nemours Children's Clinic. The registered enrollment target is 73 participants, below the 2,531-participant average among 4 other Epistaxis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02517294, a NA study of Epistaxis, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparison is made between standard nasotracheal tubes and a specially designed nasotracheal tube during nasotracheal intubation in children undergoing general anesthesia for dental surgery.
Conditions Studied
Interventions
- DEVICE Parker flex-tip nasotracheal tube
- DEVICE Standard nasotracheal tube
Study Locations (1)
Florida
- Wolfson Children's Hospital - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02517294
The ClinicalTrials.gov registry entry for NCT02517294 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,531-participant average among 4 other Epistaxis trials with a reported enrollment target (97% lower). The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Epistaxis appearing as the primary indexed condition, and to 2 interventions - of which Parker flex-tip nasotracheal tube is the first listed.
NCT02517294 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02517294 about?
NCT02517294 is a clinical study titled ", "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"". Comparison is made between standard nasotracheal tubes and a specially designed nasotracheal tube during nasotracheal intubation in children undergoing general anesthesia for dental surgery.
What is the current status of trial NCT02517294?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2015-06. Estimated completion is 2019-08.
What conditions does trial NCT02517294 study?
This clinical trial studies the following conditions: Epistaxis.
What interventions are being tested in trial NCT02517294?
The interventions under investigation include: Parker flex-tip nasotracheal tube (DEVICE), Standard nasotracheal tube (DEVICE).
Who is sponsoring clinical trial NCT02517294?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02517294 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epistaxis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
COMPLETED · NA
-
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
RECRUITING
-
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)
ACTIVE NOT RECRUITING · Phase 2
-
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.